ACP-105
Also known as: ACP105
Classification
Sarm
Regulatory Status
not-established
Sources
2
Review
n/a
Overview
ACP-105 is described as an orally studied selective androgen receptor modulator intended for tissue-selective anabolic signaling. Human clinical efficacy and safety are not established.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
Interactions & cautions
Drug interactions
androgens, anabolic steroids, or other SARMs — Potential additive androgen-pathway effects; no specific clinical interaction studies identified. (high)
These are observational flags for review, not individualized instructions.
Sources
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw